4 MEIP's, page-5

Hey, BW, just did about a 30 min search on US Patent office site and could not find a Novogen/tropomoysin patent application.
What Moosey said about Pracinostat being unrelated to Novogen is right. MEIP bought that from some other co.
The whole tweet thing was primarily to show valuation of MEIP is relatively low. Their ongoing trial vs. AML just gets better the longer it goes, as it's measuring survival of patients. Been 22 or 23 months now, I think, which is great for AML patients.